Latest Form 4 insider transactions

NASDAQ
Dirk Huebner, SVP, CMO of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
NASDAQ
Grady Grant Iii, a Director of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
NASDAQ
Marvin L White, Executive Chair and a Director of Aptevo Therapeutics Inc., reported multiple transactions in common stock on July 17, 2026.
NASDAQ
Daniel Abdun-Nabi, a Director of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
NASDAQ
Barbara Lopez Kunz, a Director of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
NASDAQ
Jeffrey W. Albers, a Director of Spyre Therapeutics, Inc., sold 23,000 shares of common stock on August 7, 2026.
NASDAQ
John Niederhuber, a Director of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
NASDAQ
Anne Busquet, a Director of CareCloud, Inc., reported multiple transactions in common stock on August 8, 2026.
NASDAQ
Bill Korn, a Director of CareCloud, Inc., reported multiple transactions in common stock on August 8, 2026.
NASDAQ
Cameron Munter, a Director of CareCloud, Inc., reported multiple transactions in common stock on August 8, 2026.
NASDAQ
Lawrence Steven Sharnak, a Director of CareCloud, Inc., reported multiple transactions in common stock on August 8, 2026.
NYSE
Matthew J Mcnulty, SVP, CFO of Ethan Allen Interiors Inc, reported a transaction in 239 shares of common stock on August 10, 2026.
NYSE
Amy Phillips, EVP, Retail Division of Ethan Allen Interiors Inc, reported a transaction in 417 shares of common stock on August 10, 2026.
NYSE
Arnold D Martines, Chairman, President & CEO of Central Pacific Financial Corp, reported a transaction in 2,750 shares of common stock on August 7, 2026.
NYSE
M Farooq Kathwari, Chairman, President & CEO and a Director of Ethan Allen Interiors Inc, reported a transaction in 3,272 shares of common stock on August 10, 2026.
NASDAQ
Discovery Capital Management, Llc / Ct and 2 others reported changes in beneficial ownership of Ramaco Resources, Inc. common stock on August 6, 2026.
NYSE
Freddy P. Bharucha, CEO - Beauty of PROCTER & GAMBLE Co, reported multiple transactions in common stock on August 6, 2026.
NYSE
Eschenbach Andrew C. Von, a Director of Bausch & Lomb Corp, sold 18,559 shares of common stock on August 6, 2026.
NASDAQ
Steven B. Binder, a Director of Mannkind Corp, sold 39,051 shares of common stock on August 7, 2026 for $4.06 per share.
NYSE
Charles R. Schwab, Co-Chairman and a Director of Schwab Charles Corp, reported a transaction in 37,200 shares of common stock on August 6, 2026.
NYSE
ORCP III DE TopCo GP, LLC and 4 others reported changes in beneficial ownership of Primo Brands Corp common stock on August 7, 2026.
NASDAQ
George Kurtz, PRESIDENT AND CEO and a Director of CrowdStrike Holdings, Inc., sold 20,000 shares of common stock on August 6, 2026.
NYSE
Tony W Lee, a Director and 10% owner of Primo Brands Corp, sold 20,410,340 shares of common stock on August 7, 2026 for $24.37 per share.
NASDAQ
Omar Ishrak, a Director of Amgen Inc, received 85 shares of common stock on August 7, 2026.
NYSE
Christopher L. Finazzo, Chief Commercial Officer of United Parks & Resorts Inc., sold 6,622 shares of common stock on August 6, 2026 for $44.20 per share.
NASDAQ
Charles M Holley, a Director of Amgen Inc, received 103 shares of common stock on August 7, 2026.
NASDAQ
Michael Drake V, a Director of Amgen Inc, received 64 shares of common stock on August 7, 2026.
NASDAQ
Torsten Kreindl, a Director of SITIME Corp, sold 1,050 shares of common stock on August 7, 2026.
NASDAQ
Douglas J Herrington, CEO Worldwide Amazon Stores of Amazon Com Inc, reported a transaction in 22,000 shares of common stock on August 6, 2026.
NASDAQ
Stephen L Rohde, a Director of Slide Insurance Holdings, Inc., sold 5,000 shares of common stock on August 6, 2026 for $21.00 per share.